Genetic Variants Associated with Tacrolimus Metabolism in Kidney Transplant Recipients

Loading...
Thumbnail Image

Persistent link to this item

Statistics
View Statistics

Journal Title

Journal ISSN

Volume Title

Title

Genetic Variants Associated with Tacrolimus Metabolism in Kidney Transplant Recipients

Published Date

2023-08

Publisher

Type

Thesis or Dissertation

Abstract

This master’s thesis focuses on the work completed during my K01 award Genetic Variants Associated with Tacrolimus (TAC) metabolism in Kidney Transplant Recipients. In Chapter 1, I discuss the significance and innovations of this project. In Chapter 2, I present reformatted manuscript published in the Pharmacogenomics Journal titled: Identification of genetic variants associated with tacrolimus metabolism in kidney transplant recipients by extreme phenotype sampling and next generation sequencing. In Chapter 3, I present a reformatted manuscript published in Drug Metabolism and Disposition titled: CRISPR/Cas9 genetic modification of CYP3A5 *3 in human hepatocytes leads to cell lines with increased midazolam and tacrolimus metabolism. Chapter 4 is the general conclusions, future directions and take away messages.

Description

University of Minnesota M.S. thesis. August 2023. Major: Biomedical Informatics and Computational Biology. Advisor: Ajay Israni. 1 computer file (PDF); viii, 93 pages.

Related to

Replaces

License

Series/Report Number

Funding information

Isbn identifier

Doi identifier

Previously Published Citation

Suggested citation

Dorr, Casey. (2023). Genetic Variants Associated with Tacrolimus Metabolism in Kidney Transplant Recipients. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/259530.

Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.